These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 7887639)
1. [Clinical effects of carmofur (Mifurol) on advanced and recurrent breast cancer in a cooperative study. Research association for re-evaluation of direct effects of Mifurol on breast cancer]. Kusama M; Tominaga T; Enomoto K; Yoshida M; Koyama H; Sonoo H; Takashima S; Abe R; Nishi T; Yamaguchi S Gan To Kagaku Ryoho; 1995 Mar; 22(4):467-75. PubMed ID: 7887639 [TBL] [Abstract][Full Text] [Related]
2. [Study on effectiveness of carmofur (Mifurol) in urogenital carcinoma, especially bladder cancer, as a post-operative adjuvant chemotherapeutic agent]. Nishio S; Kishimoto T; Maekawa M; Kawakita J; Morikawa Y; Funai K; Hayahara N; Yuki K; Nishijima T; Yasumoto R Hinyokika Kiyo; 1987 Feb; 33(2):295-303. PubMed ID: 3591594 [TBL] [Abstract][Full Text] [Related]
3. [Late phase II study of KW-2307 in advanced or recurrent breast cancer. KW-2307 Cooperative Study Group (Breast Cancer Section)]. Tominaga T; Nomura Y; Adachi I; Aoyama H; Nagao K; Mitsuyama S; Nakamura Y; Ogita M; Sano M; Takashima S Gan To Kagaku Ryoho; 1994 May; 21(6):809-16. PubMed ID: 8185338 [TBL] [Abstract][Full Text] [Related]
4. [Early phase II study of KW-2307 in advanced or recurrent breast cancer. KW-2307 Cooperative Study Group (Breast Cancer Section]. Tominaga T; Nomura Y; Adachi I; Takashima S; Kimura M; Koyama H; Toge T; Tamura K; Hayasaka H; Kunii Y Gan To Kagaku Ryoho; 1994 May; 21(6):801-8. PubMed ID: 8185337 [TBL] [Abstract][Full Text] [Related]
6. [Clinical evaluation of CGS16949A in advanced or recurrent breast cancer--a multi-institutional late phase II clinical trial]. Aoyama H; Asaishi K; Abe R; Kajiwara T; Enomoto K; Yoshida M; Ohasi Y; Tominaga T; Abe O Gan To Kagaku Ryoho; 1994 Mar; 21(4):477-84. PubMed ID: 8129388 [TBL] [Abstract][Full Text] [Related]
7. [A phase II study of 590-S (1-phthalidyl-5-fluorouracil) in patients with breast cancer--multi-center cooperative study--Cooperative Study Group of 590-S in Breast Cancer]. Taguchi T; Terasawa T Gan To Kagaku Ryoho; 1987 Feb; 14(2):467-71. PubMed ID: 3813575 [TBL] [Abstract][Full Text] [Related]
8. [Phase II study of NK 622 (toremifene citrate) in advanced breast cancer, a multicentral cooperative dose finding study]. Tominaga T; Abe O; Izuo M; Nomura Y Gan To Kagaku Ryoho; 1993 Jan; 20(1):79-90. PubMed ID: 8422189 [TBL] [Abstract][Full Text] [Related]
9. Postoperative adjuvant use of carmofur for early breast cancer. Morimoto K; Koh M Osaka City Med J; 2003 Dec; 49(2):77-83. PubMed ID: 15179836 [TBL] [Abstract][Full Text] [Related]
10. [Long-term administration of carmofur as a post-operative adjuvant chemotherapy for cervical adenocarcinoma. Cervical Adenocarcinoma Cooperative Research Association]. Ikeda M; Teshima K; Noda K; Yamagata S; Sugawa T; Okamura S; Kubo H; Sugimoto O; Nakajima H; Yamabe T Gan To Kagaku Ryoho; 1994 Sep; 21(12):1967-74. PubMed ID: 8085847 [TBL] [Abstract][Full Text] [Related]
11. Phase II trial of oral carmofur in advanced pancreatic carcinoma. Kajanti MJ; Pyrhönen SO Ann Oncol; 1991; 2(10):765-6. PubMed ID: 1801884 [TBL] [Abstract][Full Text] [Related]
12. [Clinical evaluation of NK 622 (toremifene citrate) in advanced or recurrent breast cancer--a comparative study by a double blind method with tamoxifen]. Nomura Y; Tominaga T; Abe O; Izuo M; Ogawa N Gan To Kagaku Ryoho; 1993 Feb; 20(2):247-58. PubMed ID: 8434963 [TBL] [Abstract][Full Text] [Related]
13. [Phase II study of carmofur (HCFU) fine granules]. Koyama Y Gan To Kagaku Ryoho; 1982 May; 9(5):906-14. PubMed ID: 7184433 [TBL] [Abstract][Full Text] [Related]
14. [Clinical trial of 5'-DFUR in patients with recurrent breast cancer]. Morimoto T; Komaki K; Yamakawa T; Tanaka T; Konishi Y; Uomine Y; Miki H; Ooshimo K; Monden Y Gan To Kagaku Ryoho; 1988 Oct; 15(10):2983-9. PubMed ID: 2972258 [TBL] [Abstract][Full Text] [Related]
15. [Early phase II study of TAT-59 in patients with advanced or recurrent breast cancer--a multicenter dose finding study]. Aoyama H; Tominaga T; Abe O Gan To Kagaku Ryoho; 1998 May; 25(6):853-65. PubMed ID: 9617324 [TBL] [Abstract][Full Text] [Related]
17. [A randomized controlled study of (2'' R)-4'-O-tetrahydropyranyladriamycin and adriamycin in combination with cyclophosphamide and 5-fluorouracil in the treatment of advanced and recurrent breast cancer]. Abe O; Tominaga T; Enomoto K; Abe R; Iino Y; Koyama H; Fujimoto M; Nomura Y; Tanaka T Gan To Kagaku Ryoho; 1986 Jun; 13(6):2160-8. PubMed ID: 3717960 [TBL] [Abstract][Full Text] [Related]
18. [A randomized controlled trial comparing short-term MF chemotherapy with MF and long-term carmofur chemotherapy as an adjuvant to curative resection of stomach cancer]. Nakazato H; Koike A; Ichihashi H Gan No Rinsho; 1986 Feb; 32(2):159-64. PubMed ID: 3083146 [TBL] [Abstract][Full Text] [Related]
19. [Clinical evaluation of cyclophosphamide, methotrexate and 5-fluorouracil (CMF) on advanced and recurrent breast cancer. Clinical study group of CMF for breast cancer in Japan]. Nomura Y; Tominaga T; Adachi I; Koyama H; Fukami A Gan To Kagaku Ryoho; 1994 Sep; 21(12):1949-56. PubMed ID: 8085846 [TBL] [Abstract][Full Text] [Related]
20. [A comparative study of 5'-DFUR and tegafur in recurrent breast cancer]. Taguchi T; Terasawa T; Abe O; Yoshida Y; Tominaga T; Ogawa N Gan To Kagaku Ryoho; 1985 Oct; 12(10):2052-60. PubMed ID: 2932060 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]